Sleep Support Peptide
2mg
DSIP (Delta Sleep-Inducing Peptide) is a natural neuropeptide that supports healthy sleep architecture by promoting deep restorative sleep, optimizing sleep cycles, and enhancing overall sleep quality without sedation or dependency. This sophisticated sleep peptide works through multiple mechanisms including circadian rhythm regulation, stress hormone modulation, and sleep stage optimization to naturally improve sleep onset, duration, and quality. Ideal for individuals seeking improved sleep patterns, recovery enhancement, circadian rhythm restoration, and comprehensive sleep wellness under physician supervision.
Deep
Sleep Support
Natural
Sleep Cycles
Enhanced
Recovery
Screened
Sleep History First
Available Dosing
Precision-formulated DSIP designed for optimal sleep architecture support and restorative sleep enhancement under comprehensive medical supervision.
Standard sleep support
Ideal For
Individuals seeking improved sleep quality, enhanced deep sleep, sleep cycle optimization, recovery support, circadian rhythm restoration, or natural sleep support without sedation under medical guidance.
The Science
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide first isolated from the cerebral venous blood of sleeping rabbits, demonstrating remarkable ability to promote deep, restorative sleep and optimize sleep architecture through sophisticated neurological mechanisms. This endogenous peptide works fundamentally differently from conventional sleep medications—rather than forcing sedation or suppressing neural activity, DSIP supports the body's natural sleep-wake regulatory systems including circadian rhythm optimization, stress hormone balance, and sleep stage progression. Research indicates DSIP enhances delta wave sleep (the deepest, most restorative sleep phase), improves overall sleep quality, supports recovery processes that occur during sleep, and helps restore healthy sleep patterns disrupted by stress, aging, travel, or shift work.
The mechanisms of action involve modulation of sleep-regulating neurotransmitters and neuroendocrine systems including enhancement of delta wave activity during deep sleep stages, regulation of cortisol and stress hormone rhythms that impact sleep quality, optimization of circadian rhythm signaling for proper sleep-wake cycles, support for melatonin and sleep-promoting pathways, and modulation of pain perception which can interfere with sleep quality. Unlike sedative-hypnotics that suppress REM sleep and create dependency, DSIP appears to support natural sleep architecture allowing normal progression through all sleep stages while specifically enhancing the deepest, most restorative phases. Small studies from the 1980s and 1990s reported mixed effects on sleep onset and sleep efficiency (PMIDs 3622582, 1299794).
It has been studied in small trials for insomnia and is discussed for difficulty falling or staying asleep, insufficient deep sleep despite adequate sleep duration, sleep disruption from stress or irregular schedules, recovery optimization for athletes or high performers, circadian rhythm disorders from travel or shift work, sleep quality decline associated with aging, and comprehensive wellness protocols recognizing sleep as foundational to metabolic health, cognitive function, immune resilience, and longevity. Medical supervision ensures appropriate dosing protocols, monitoring for sleep quality improvements, assessment of individual response patterns, and integration with comprehensive sleep hygiene strategies including consistent sleep schedules, optimized sleep environment, light exposure management, stress reduction practices, and lifestyle factors that amplify DSIP's sleep-supporting benefits for optimal restorative sleep and recovery.
Book a Consultation
How It Works
A multi-pathway sleep peptide that optimizes sleep architecture, regulates circadian rhythms, and supports restorative sleep through comprehensive neurological mechanisms.
DSIP promotes delta wave activity during deep sleep stages, enhancing the most restorative phase of sleep where physical recovery, immune function, and memory consolidation occur optimally.
Supports natural sleep-wake cycle regulation through optimization of circadian signaling pathways, helping restore healthy sleep patterns disrupted by stress, travel, shift work, or aging processes.
Modulates cortisol and stress hormone rhythms that interfere with sleep quality, promoting balanced neuroendocrine function that supports natural sleep onset and maintenance throughout the night.
Clinical Benefits
Promotes delta wave activity and deep sleep stages where the most restorative physiological processes occur including physical recovery, immune optimization, and metabolic regulation.
Enhances overall sleep architecture, sleep efficiency, and subjective sleep quality through support for natural sleep stage progression and optimization of restorative sleep processes.
Supports natural sleep initiation by optimizing sleep-promoting neurotransmitter systems and reducing stress-related hyperarousal that interferes with falling asleep quickly and naturally.
Amplifies recovery processes that occur during deep sleep including muscle repair, tissue regeneration, immune function optimization, and metabolic restoration—critical for athletes and high performers.
Helps reset disrupted sleep-wake cycles from travel, shift work, or irregular schedules by supporting natural circadian rhythm regulation and proper timing of sleep-promoting signals.
Is discussed as a non-sedating approach to sleep support; long-term human safety data are limited.
Your Journey
Our medical team guides you through every step—from initial consultation to ongoing optimization.
Comprehensive evaluation of sleep patterns, sleep quality issues, health history, and wellness goals to determine if DSIP therapy is appropriate for your sleep optimization objectives.
Personalized dosing plan with specific administration method, frequency, timing, and duration tailored to your sleep challenges, health status, and recovery optimization goals.
Complete instructions on proper administration technique, optimal timing for sleep benefits, storage requirements, and integration with sleep hygiene practices for maximum efficacy.
Regular physician follow-ups to assess sleep quality improvements, monitor recovery benefits, adjust protocols as needed, and ensure optimal therapeutic outcomes for sleep wellness.
Safety & Candidacy
DSIP therapy requires thorough medical evaluation to ensure safe and appropriate use. This sleep peptide is designed for individuals seeking sleep quality improvement, deep sleep enhancement, recovery optimization, and comprehensive sleep wellness through evidence-based sleep architecture support.
Provider-led
Prescribed only after a provider consultation and sleep screening, with a diary-based review
Monitored
Small, older studies reported few adverse effects; long-term human safety data are limited
At a glance
Your plan
A BHRC provider asks how long the problem has lasted, what a typical night looks like, how much caffeine and alcohol you use, and which medicines you take. Snoring, witnessed pauses in breathing, morning headaches or daytime sleepiness lead to a sleep apnea evaluation first, because no peptide addresses an airway problem.
Before any prescription, you keep a simple sleep diary: bedtime, time to fall asleep, awakenings, wake time and how rested you feel. Wearable data can be added, but the diary is the record we use. Without a baseline there is no honest way to tell whether DSIP did anything.
The plan always includes the elements with the strongest evidence for chronic insomnia: a fixed wake time, limiting time in bed to time asleep, managing light and screens, and cognitive behavioral therapy for insomnia (CBT-I) where it is available. DSIP, if used, sits on top of these, not instead of them.
If your provider prescribes DSIP, the written plan states the schedule, the review date and when to stop. Evening timing is planned around your usual bedtime, and you are told not to combine it with alcohol, sleeping pills or sedating medicines unless the provider has specifically reviewed that.
At review we compare the diary against baseline. Fewer minutes to fall asleep, fewer long awakenings or better morning ratings count as change; a general sense of feeling better does not settle the question. If the diary shows no difference, the trial ends.
Timeline
Two weeks of diary and screening before starting. This is often when simple fixes, such as moving caffeine earlier or a consistent wake time, already shift the picture.
Some people report sleeping more deeply or dreaming more vividly; many notice nothing. Headache, grogginess the next morning or injection-site redness are reported and reviewed.
Check-in. The diary is compared with baseline. A clear lack of change at this point is useful information and can end the trial early, which saves time and cost.
Planned stop and review. Effects on sleep, if any, are judged against the diary and your daytime function.
Sleep habits and CBT-I skills are what tend to last. If poor sleep returns, the next step is to look for a cause rather than automatically restart a peptide.
Compare
| Option | How it works | Strength of evidence | Notes |
|---|---|---|---|
| DSIP (this page) | Uncertain; no confirmed receptor or gene | Small 1980s and 1990s trials with mixed results | Unapproved; FDA proposed against adding it to the 503A bulks list |
| CBT-I and sleep-schedule changes | Retrains sleep timing and the response to lying awake | Recommended first-line treatment for chronic insomnia in the American College of Physicians guideline | Effects tend to persist after the program ends |
| Melatonin or timing changes | Shifts the body clock signal | Useful mainly for timing problems such as jet lag and delayed sleep phase | Over-the-counter in the US; product content varies |
| Prescription sleep medicines | Various brain targets | FDA-approved options with known benefits and risks | Prescribed and monitored by your doctor |
| DSIP/Selank blend | DSIP plus an anxiety-focused peptide | No combination data | Only when worry at night is a central part of the problem |
Is it right for you?
Monitoring
Monitoring centers on the sleep diary and daytime safety. At each check-in the BHRC clinical team asks about time to fall asleep, awakenings, morning grogginess, headaches, mood changes and any falls or near-misses while driving. A short validated questionnaire, such as an insomnia severity score, may be repeated at baseline and review so changes are measured the same way each time.
If you are taking any medicine that affects the brain, including antidepressants, anxiety medicines, pain medicines or stimulants, the provider reviews that list at every visit. New snoring, choking at night or worsening daytime sleepiness during the trial means stopping and arranging a sleep evaluation.
Because DSIP research comes mainly from small, older studies and FDA has noted it found no safety information for the proposed compounding route, BHRC keeps courses short, records every reported effect and stops at the first sign of a problem.
Reviews also look at life around the trial. A stressful month, travel, a new baby or a change in work shifts can move sleep more than any peptide. The provider notes these events in the diary so a good or bad stretch is not wrongly credited to, or blamed on, DSIP.
Dosing, reconstitution and cycling detail is covered in our Provider-Led Peptide and Hormone Protocols. Your own plan is set by your provider at the consultation.
Regulatory status
Status, reviewed October 2026: DSIP (emideltide) is not an FDA-approved drug for any use. FDA had placed emideltide in Category 2 of its interim compounding policy (bulk substances that may present significant safety risks), noting it found no safety information for the proposed route; that nomination was withdrawn in 2026. FDA then evaluated emideltide for chronic insomnia, narcolepsy and opioid withdrawal and, at its July 24, 2026 Pharmacy Compounding Advisory Committee meeting, proposed that it not be included on the 503A bulks list. At BHRC, DSIP is discussed only after a consultation with a licensed BHRC provider, it does not replace evaluation of sleep apnea or other causes of poor sleep, and it is not offered to diagnose, treat or prevent any disease.
Before you book
DSIP stands for delta sleep-inducing peptide. It was isolated in 1977 from the blood of rabbits during induced sleep and named for its apparent effect on deep (delta) sleep. Researchers have since struggled to identify its gene, its precursor protein or a specific receptor, and a 2006 review described it as a still unresolved riddle. It is not FDA-approved.
Honestly, nobody knows with confidence. Proposed effects on stress hormones, sleep stages and pain have been described in animal work, but without a confirmed receptor the mechanism remains a hypothesis. Websites that describe a precise mechanism are going beyond the evidence. Part of the difficulty is that DSIP-like activity measured in blood and brain tissue may not even come from DSIP itself, which is one of the hypotheses researchers have raised.
The human evidence is small and mixed. A 1987 placebo-controlled study of 14 people with severe chronic insomnia reported better sleep and daytime function. A 1992 double-blind study of 16 people found only weak effects and concluded that short-term DSIP was unlikely to be of major benefit. Neither is enough to establish that it works. Both used intravenous DSIP under laboratory conditions, and both were too small and too short to say anything about safety or benefit over months of home use.
Reports in the published studies were limited. In practice, people mention headache, next-morning grogginess, vivid dreams and injection-site redness. Because human safety data is sparse, BHRC treats any new symptom cautiously, and anyone who feels impaired the next morning should not drive until it is reviewed.
No. FDA had placed emideltide (DSIP) in Category 2 of its interim compounding policy; that nomination was withdrawn in 2026. FDA then evaluated it on its own initiative, and at its July 2026 advisory committee meeting proposed that emideltide not be included on the 503A bulks list.
They do different things. Melatonin is a timing signal and is most useful when the problem is when you sleep, for example after travel or with a late body clock. DSIP's effect, if any, is uncertain. For most people with chronic insomnia, CBT-I and schedule changes come before either. If you already take melatonin, tell your provider; adding several sleep-promoting products at once makes it impossible to judge any single one.
If prescribed, your provider teaches you in person and writes the timing into your plan. BHRC has not published a DSIP dosage guide. For how supervision of peptide protocols works, see Provider-Led Peptide and Hormone Protocols.
We do not publish prices on this page. The total depends on the length of the trial, vial supply, the consultation, any screening tests such as a sleep study referral, and follow-up visits. You receive an itemized quote at consultation. If a sleep study is needed first, that is arranged and priced separately, and it can change the plan entirely.
BHRC lists a DSIP/Selank blend for people whose sleep problem is closely tied to nighttime worry. Combining agents makes it harder to know what helped, so a single-agent trial or a non-peptide plan is usually discussed first. If anxiety drives the sleeplessness, treating the anxiety directly is often the more effective route.
Book a consultation through Start Your Journey or call the clinic. If you can, arrive with a week or two of sleep notes and a list of every medicine and supplement you take in the evening, including over-the-counter sleep aids.
Selected research
The literature below is peer-reviewed background on DSIP and the mechanisms discussed on this page, so you can read the primary sources yourself. It is not evidence of any particular outcome at BHRC, and some of it is preclinical work in animals or cells. Your provider will discuss what the evidence does and does not support for your situation.
Related peptide therapies
Peptide therapy
Nootropic Peptide Therapy • Cognitive Support
Questions
DSIP operates through fundamentally different mechanisms compared to conventional sleep medications like benzodiazepines, Z-drugs, or sedating antihistamines. While traditional sleep aids force sedation by suppressing neural activity and often disrupt natural sleep architecture (particularly REM sleep), DSIP supports the body's endogenous sleep-regulating systems to promote natural, restorative sleep with proper progression through all sleep stages. Unlike pharmaceutical sleep aids that cause next-day drowsiness, cognitive impairment, tolerance, and dependency, DSIP enhances sleep quality without sedative side effects, maintains normal sleep architecture, causes no morning grogginess, develops no tolerance requiring dose escalation, and demonstrates no withdrawal symptoms or addiction potential. DSIP specifically enhances delta wave sleep—the deepest, most restorative phase—while preserving REM sleep critical for cognitive function and emotional processing. DSIP is discussed for sleep quality goals; it is not a treatment for insomnia.
DSIP is ideal for individuals experiencing insufficient deep sleep despite adequate total sleep time, difficulty falling asleep or maintaining sleep, poor sleep quality affecting daytime function, recovery challenges in athletic or high-performance contexts, circadian rhythm disruption from travel or shift work, or age-related sleep quality decline. It's particularly valuable for those seeking natural sleep support without pharmaceutical side effects, athletes and performers requiring optimal recovery, professionals whose performance depends on sleep quality, individuals who haven't responded well to or experienced side effects from traditional sleep medications, patients interested in sleep optimization for longevity and metabolic health, or anyone preferring evidence-based peptide therapy for comprehensive sleep wellness. Our physicians evaluate your sleep patterns, sleep quality issues, health history, current medications, and wellness goals to determine if DSIP's sleep-supporting mechanisms are appropriate. It's may suit patients interested in a supervised, research-stage approach to sleep quality.
DSIP is typically administered through subcutaneous injection, usually in the evening 30-60 minutes before desired sleep time to align with natural sleep onset. Subcutaneous administration provides reliable bioavailability and consistent sleep-supporting effects throughout the night. Some protocols may utilize intranasal delivery for specific therapeutic needs. Your physician will provide detailed instructions regarding proper administration technique, optimal timing for your sleep patterns (typically evening administration), dosing frequency (which may range from nightly to several times per week depending on sleep needs and protocol design), and any cycling strategies. The peptide should be stored refrigerated to maintain stability and potency. Our medical team ensures you're comfortable with administration technique and provides comprehensive guidance tailored to your specific protocol and sleep optimization objectives including integration with sleep hygiene practices that amplify DSIP's benefits.
DSIP has limited human safety data and is used only under proper medical supervision with appropriate dosing protocols. Most patients experience no adverse effects beyond improved sleep quality. When present, side effects are typically mild and transient, potentially including slight drowsiness if administered too early (easily resolved by timing adjustment), mild headaches during initial adaptation in some individuals (usually resolving within days), temporary vivid dreams as sleep architecture normalizes, or rare reports of mild dizziness upon waking in sensitive individuals. Critically, DSIP does NOT cause the next-day sedation, cognitive impairment, memory problems, tolerance, withdrawal symptoms, or addiction associated with conventional sleep medications. Tolerance, rebound insomnia and dependence have not been well studied in humans. Serious adverse reactions are exceptionally rare. Our physicians monitor your response carefully through regular follow-ups and sleep quality assessments to optimize sleep benefits while minimizing any adaptation effects.
DSIP protocols are highly individualized based on sleep quality issues, underlying causes, and wellness goals. Many patients begin with 4-8 week initial cycles to establish baseline response and assess sleep quality improvements, with protocols often extending to 12+ weeks for comprehensive sleep pattern restoration. Some patients use DSIP for specific periods of sleep disruption (travel, high-stress periods, training cycles requiring optimal recovery) with targeted short-term protocols, while others implement ongoing protocols with periodic cycling for sustained sleep optimization. Because DSIP supports fundamental sleep regulatory systems and can help restore healthy circadian rhythms, many sleep quality benefits persist beyond immediate treatment periods as natural sleep architecture improves. Treatment duration depends on your sleep quality baseline, underlying sleep issues, response to therapy, whether you're addressing acute sleep disruption or chronic sleep quality challenges, and your physician's assessment. Our doctors design personalized protocols and adjust duration based on sleep quality assessments and your wellness objectives.
DSIP may be combined with other sleep wellness approaches including cognitive behavioral therapy for insomnia (CBT-I), sleep hygiene optimization, other recovery-supporting peptides, magnesium and sleep-supporting supplements, melatonin (under medical guidance), adaptogenic herbs, and comprehensive sleep optimization protocols when properly coordinated under medical supervision. In fact, combining DSIP with complementary therapies may provide synergistic benefits through multiple sleep-supporting pathways. However, you must disclose all current medications especially sleep medications, psychiatric medications, sedatives, supplements, and any substances affecting sleep or neural function to our physicians during consultation. We'll review potential interactions, assess synergistic opportunities, and design an integrated protocol that maximizes sleep quality while maintaining safety. Some approaches like consistent sleep schedules, optimized sleep environment (temperature, darkness, quiet), regular exercise (timed appropriately relative to sleep), stress reduction practices, and proper light exposure timing may amplify DSIP's sleep-supporting effects for comprehensive sleep wellness enhancement and optimal restorative sleep.
Sleep quality improvement timelines with DSIP vary based on individual physiology, baseline sleep quality, underlying sleep issues, and wellness goals. Many patients notice initial sleep benefits including easier sleep onset, fewer nighttime awakenings, or feeling more rested upon waking within the first few nights of therapy due to immediate effects on sleep-regulating systems. More substantial benefits including consistent deep sleep enhancement, comprehensive sleep architecture optimization, and robust recovery improvements typically develop over 1-4 weeks as circadian rhythms stabilize and sleep patterns normalize. Maximum benefits including sustained high-quality sleep and long-term sleep wellness often manifest over 4-12 weeks of consistent therapy. Response timelines depend on sleep issue severity, underlying causes (stress, circadian disruption, aging, etc.), genetic sleep factors, concurrent sleep hygiene practices, protocol adherence, and dosing optimization. Some patients experience rapid sleep onset improvement while others notice gradual progressive enhancement of deep sleep quality. Complete therapeutic benefits develop throughout comprehensive sleep optimization protocols with sustained improvements often persisting as healthy sleep patterns become re-established.
Get Started
Schedule a consultation with our medical team to learn if DSIP peptide therapy is right for your sleep optimization and wellness goals.
"*" indicates required fields
Or call us directly: +1 213-325-3373
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. DSIP is a research peptide and is not FDA-approved for human use in the United States. This therapy is provided only under physician supervision. DSIP should not replace conventional medical treatment for serious sleep disorders, sleep apnea, or underlying medical conditions affecting sleep. Sleep therapy requires thorough medical evaluation and ongoing monitoring. Individual results may vary. A consultation with our medical team and comprehensive sleep assessment are required to determine if this therapy is appropriate for you.
